10.1002/asia.201800645
Chemistry - An Asian Journal
FULL PAPER
(1,4-isomer), 38.3 (1,2-isomer), 40.3 (1,4-isomer), 54.7 (1,2-isomer), 60.1,
60.3, 60.4, 60.7, 61.0, 89.9, 106.4, 109.0, 113.5, 122.5, 131.8, 137.0,
138.8, 138.9, 143.2, 143.4, 165.0, 165.4, 169.9; HRMS calcd. for
C21H25INO6 [M+H] +: 514.0727, found: 514.0731.
2E,4Z and 2E,4E 1:1): 1.31 (t, 3H, J 7.0 Hz), 1.32 (t, 3H, J 7.5 Hz),
1.36 (t, 3H, J 7.2 Hz), 1.41 (t, 3H, J 7.2 Hz), 4.22 (q, 2H, J 7.5 Hz),
4.24 (q, 2H, J 7.0 Hz), 4.30 (q, 2H, J 7.2 Hz), 4.35 (q, 2H, J 7.2 Hz),
6.27 (d, 1H, J 16.0 Hz, 2E,5Z), 6.59 (d, 1H, J 15.5 Hz, 2E,5E), 7.14
(d, 2H, J 9.5 Hz, 2E,5Z), 7.17 (d, 2H, J 9.0 Hz, 2E,5E), 7.45 (d, 1H, J
16.0 Hz, 2E,5Z), 7.60 (d, 1H, J 15.5 Hz, 2E,5E), 7.74 (d, 1H, J 13.0
Hz, 2E,5Z), 7.92 (d, 1H, J 14.0 Hz, 2E,5E), 8.14 (d, 1H, J 14.0 Hz,
2E,5E), 8.25 (d, 2H, J 9.5 Hz, 2E,5Z), 8.25 (d, 2H, J 9.0 Hz, 2E,5E),
8.25 (d, 2H, J 9.5 Hz, 2E,5Z), 11.02 (d, 1H, J 13.0 Hz, 2E,5Z); 13C
NMR (125.8 MHz, CDCl3): 14.3, 14.4, 14.4, 60.2, 60.6, 60.8, 61.1, 102.3,
104.4, 114.1 (2E,5Z), 115.4, 115.6, 119.4 (2E,5E), 126.1 (2E,5Z), 126.1
(2E,5E), 134.2 (2E,5E), 140.5 (2E,5E), 140.8 (2E,5Z), 143.1, 143.3,
144.6, 144.7, 145.4, 166.2, 167.8, 168.1, 168.6; HRMS calcd. for
C16H18N2NaO6 [M+Na] +: 357.1063, found: 357.1053.
3p: Z isomer, orange solid, mp 127-129 C; IR 3294, 3112, 1668, 1639,
1600, 1334 cm1; 1H NMR (200 MHz, CDCl3) 1.32 (t, 3H, J = 7.2 Hz),
4.21 (q, 2H, J = 7.2 Hz), 5.06 (d, 1H, J = 8.6 Hz), 7.00 (d, 2H, J = 9.2 Hz),
7.27 (dd, 1H, J = 8.6 Hz, J 12.2 Hz), 8.20 (d, 2H, J = 9.2 Hz), 10.29 (d,
1H, J = 12.2 Hz); 13C NMR (50.3 MHz, CDCl3): 14.1, 59.9, 92.3, 114.1,
126.1, 140.5, 142.0, 146.0, 169.8; HRMS calcd. for C11H13N2O4 [M+H] +:
237.0875, found: 237.0865.
(2E,4Z)- and (2E,4E)-diethyl 4-(((4-fluorophenyl)amino)methylene)-
pent-2-enedioate (4o)
Method A: 46.0 mg (35%) from 1o (48.0 mg, 0.43 mmol) and 2a (168.7
mg, 1.72 mmol) in EtOH (1.5 mL) during 120 h, along with 3o (41.0 mg,
45%) and 5/5'o (10.0 mg, 6%).
Method B: 80.0 mg (60%) from 1o, 48.0 mg, 0.43 mmol) and 2a (168.7
mg, 1.72 mmol) during 72 h, along with 3o (10.0 mg, 11%) and 5/5'o
(17.0 mg, 10%).
Method C: 52.0 mg (63%) from 1o (30.0 mg, 0.27 mmol) and 2a (53.0
mg, 0.54 mmol) during 9 h, along with 5/5'o (23.0 mg, 21%) and 6a (1.1
mg; 2%).
4o: pale yellow solid, mp 70-72 C (lit.12c 74-78 C), IR (2E,4Z and 2E,4E
10:1) 3422, 1676, 1655, 1593 cm1; 1H NMR (500.3 MHz, CDCl3, 2E,4Z
and 2E,4E 10:1): 1.31 (t, 3H, J = 7.0 Hz, 2E,4Z), 1.34 (t, 3H, J = 7.0 Hz,
2E,4E), 1.39 (t, 3H, J = 7.0 Hz, 2E,4Z), 4.21 (q, 2H, J = 7.0 Hz, 2E,4Z),
4.26 (q, 2H, J = 7.0 Hz, 2E,4E), 4.31 (q, 2H, J = Hz, 2E,4Z), 6.18 (d, 1H,
J = 16.0 Hz, 2E,4Z), 6.57 (d, 1H, J = 15.7 Hz, 2E,4E), 7.03-7.07 (m, 4H,
2E,4Z and 2E,4E), 7.32 (d, 1H, J = 12.5 Hz, 2E,4E), 7.46 (d, 1H, J = 16.0
Hz, 2E,4Z), 7.65 (d, 1H, J = 13.0 Hz, 2E,4Z), 7.67 (d, 1H, J = 15.7 Hz,
2E,4E), 10.75 (d, 1H, J = 13.0 Hz, 2E,4Z); 13C NMR (125.8 MHz, CDCl3):
14.3, 14.3, 59.8, 60.4, 98.5, 111.0, 116.5 (d, JC-F 23.1 Hz), 118.1 (d, JC-
F 6.8 Hz), 135.7 (d, JC-F 2.4 Hz), 159.5 (d, JC-F 244.2 Hz), 168.3,
168.9.
5p and 5'p: yellow-brown solid; IR 1710, 1692, 1635, 1596, 1553, 1518,
1
1344 cm1; H NMR (500.3 MHz, CDCl3, mixture of 1,4- and 1,2-isomers
1:4): 1.16 (t, 3H, J = 7.0 Hz, 1,4-isomer), 1.19 (t, 3H, J = 7.0 Hz, 1,2-
isomer), 1.33 (t, 9H, J = 7.0 Hz, 1,2- and 1,4-isomer), 1.36 (t, 3H, J = 7.0
Hz, 1,2-isomer), 2.56-2.60 (dd, 1H, J = 6.5 Hz, J = 14.0 Hz, 1,2-isomer),
2.64 (d, 2H, J = 4.5 Hz, 1,4-isomer), 2.65-2.69 (dd, 1H, J = 6.5 Hz, J =
14.0 Hz, 1,2-isomer), 3.99-4.07 (m, 4H, 1,2- and 1,4-isomer), 4.21-4.33
(m, 9H, 1,2- and 1,4-isomer), 5.71 (dt, 1H, J = 1.5 Hz, J = 6.5 Hz, 1,2-
isomer), 7.36 (d, 2H, J = 9.0 Hz, 1,4-isomer), 7.44 (d, 2H, J = 9.0 Hz, 1,2-
isomer), 7.68 (s, 2H, 1,4-isomer), 7.69 (s, 1H, 1,2-isomer), 7.89 (s, 1H,
1,2-isomer), 8.29 (d, 2H, J = 9.0 Hz, 1,2-isomer), 8.30 (d, 2H, J = 9.0 Hz,
1,4-isomer); 13C NMR (125.8 MHz, CDCl3, 1,4- and 1,2-isomer 1:4): 14.7,
14.9, 15.0, 15.1, 15.2, 30.4 (1,4-isomer), 38.8 (1,2-isomer), 40.5 (1,4-
isomer), 54.4 (1,2-isomer), 60.8, 61.5, 61.7, 61.9, 109.5, 111.8, 117.0,
3o: Z isomer, pale yellow solid, mp 36-38 C (lit.[15] 35-38 C); IR 3366,
1665, 1594, 1512 cm1; 1H NMR (500.3 MHz, CDCl3): 1.30 (t, 3H, J = 7.0
Hz), 4.18 (q, 2H, J = 7.0 Hz), 4.83 (d, 1H, J = 8.5 Hz), 6.90-6.92 (m, 2H),
7.00 (t, 2H, J = 8.5 Hz), 7.14 (dd, 1H, J = 8.5 Hz, J = 12.5 Hz), 9.87
(broad d, 1H, J = 12.5 Hz); 13C NMR (125.8 MHz, CDCl3): 14.4, 59.3,
87.4, 116.3 (d, JC-F 22.6 Hz), 116.7 (d, JC-F 7.5 Hz), 137.1, 143.5,
158.6 (d, JC-F 241.5 Hz), 170.4.
5o and 5'o: yellow solid, only 1,4-isomer was already reported;[15] IR
1733, 1692, 1628, 1511 cm1; 1H NMR (500.3 MHz, CDCl3, 1,4- and 1,2-
isomer 1:2): 1.15 (t, 3H, J = 7.0 Hz, 1,2-isomer), 1.18 (t, 3H, J = 7.0 Hz,
1,4-isomer), 1.29-1.35 (m, 12H, 1,2- and 1,4-isomers), 2.48-2.52 (dd, 1H,
J = 6.0 Hz, J = 13.7 Hz, 1,2-isomer), 2.60 (d, 2H, J = 5.0 Hz, 1,4-isomer),
2.63-2.67 (dd, 1H, 6.0 Hz, J = 13.7 Hz, 1,2-isomer), 3.91-4.07 (m, 4H,
1,2- and 1,4-isomers), 4.22-4.28 (m, 8H, 1,2- and 1,4-isomers), 5.60 (dt,
1H, J = 1.5 Hz, J = 6.0 Hz, 1,2-isomer), 7.10-7.13 (m, 4H, 1,2- and 1,4-
isomers), 7.20-7.22 (m, 2H, 1,4-isomer), 7.30-7.33 (m, 2H, 1,2-isomer),
7.48 (s, 2H, 1,4-isomer), 7.72 (d, 1H, J = 1.0 Hz, 1,2-isomer), 7.77 (t, 1H,
J = 1.5 Hz, 1,2-isomer); 13C NMR (125.8 MHz, CDCl3, 1,4- and 1,2-
isomer 1:2): 15.5, 15.8, 15.9, 16.1, 31.1 (1,4-isomer), 39.9 (1,2-isomer),
42.0 (1,4-isomer), 57.2 (1,2-isomer), 61.6, 61.8, 61.9, 62.2, 62.5, 106.8,
109.8, 114.1, 118.2 (d, JC-F 23.9 Hz, 1,2-isomer), 118.2 (d, JC-F 22.6
Hz, 1,4-isomer), 124.7 (d, JC-F 8.8 Hz, 1,4-isomer), 125.0 (d, JC-F 7.5
Hz, 1,2-isomer), 133.7, 139.4, 141.1, 141.7, 146.3, 166.7, 167.1, 168.2,
171.6, 173.2; HRMS calcd. for C21H25FNO6 [M+H] +: 406.1666, found:
406.1670.
119.6, 120.1, 126.3, 126.5, 131.7, 136.4, 141.3, 145.0, 149.0, 165.4,
+
165.6, 166.8, 170.4, 172.1; HRMS calcd. for C21H25N2O8 [MH]
:
431.1449, found: 431.1441.
(2E,4Z)- and (2E,4E)-diethyl 4-(((3-chloro-4-methylphenyl)amino)me-
thylene)pent-2-enedioate (4q)
Method A: 25.5 mg (27%), obtained in a mixture with 7q (29.0 mg of the
mixture containing 88% of 4q and 12% of 7q), from 1q (40.0 mg, 0.28
mmol) and 2a (109.9 mg, 1.12 mmol) in EtOH (1.2 mL) during 120 h,
along with 3q (32.0 mg, 47%) and 5/5'q (9.0 mg, 7%).
Method B: 52.4 mg (55%), obtained in a mixture with 7q (57.0 mg of the
mixture containing 92% of 4q and 8% of 7q), from 1q (40.0 mg, 0.28
mmol) and 2a (109.9 mg, 1.12 mmol) during 96 h, along with 3q (9.0 mg,
13%) and 5/5'q (15.0 mg, 12%).
Method C: 41.0 mg (57%) from 1q (30.0 mg, 0.21 mmol) and 2a (41.6
mg, 0.42 mmol) during 7 h, along with 5/5'q (30.0 mg, 32%) and 6a (2.1
mg; 5%).
4q: yellow oil; IR (2E,4Z and 2E,4E 5:1) 3287, 1701, 1664, 1601 cm1
;
1H NMR (500.3 MHz, CDCl3, 2E,4Z and 2E,4E 5:1): 1.31 (t, 3H, J 7.0
Hz, 2E,4Z), 1.34 (t, 3H, J 7.5 Hz, 2E,4E), 1.39 (t, 3H, J 7.0 Hz, 2E,4Z),
2.30 (s, 3H, 2E,4E), 2.33 (s, 3H, 2E,4Z), 4.22 (q, 2H, J 7.0 Hz, 2E,4Z),
4.32 (q, 2H, J 7.0 Hz, 2E,4Z), 6.18 (d, 1H, J 15.7 Hz, 2E,4Z), 6.49 (d,
1H, J 16.0 Hz, 2E,4E), 6.86 (dd, 1H, J 2.5 Hz, J 8.0 Hz, 2E,4Z),
7.08 (d, 1H, J 2.5 Hz, 2E,4Z), 7.11 (d, 1H, J 2.0 Hz, 2E,4E), 7.19 (d,
1H, J 8.0 Hz, 2E,4Z), 7.46 (d, 1H, J 15.7 Hz, 2E,4Z), 7.60 (d, 1H, J
16.0 Hz, 2E,4E), 7.66 (d, 1H, J 13.0 Hz, 2E,4Z), 8.08 (d, 1H, J 14.0
Hz, 2E,4E), 10.70 (d, 1H, J 13.0 Hz, 2E,4Z); 13C NMR (125.8 MHz,
CDCl3, only signals for 2E,4Z isomer are clearly visible): 14.3, 14.4, 19.3,
59.9, 60.5, 98.9, 111.4, 114.9, 117.0, 131.9, 135.5, 138.3, 141.9, 147.2,
(2E,4Z)- and (2E,4E)-diethyl 4-(((4-nitrophenyl)amino)methylene)-
pent-2-enedioate (4p)
Method A: Only 3p (11.0 mg, 14%) was obtained from 1p (45.0 mg, 0.33
mmol) and 2a (125.6 mg, 1.28 mmol) in EtOH (1.3 mL) during 120 h.
Method B: 20.0 mg (18%) from 1p (45.0 mg, 0.33 mmol) and 2a (125.6
mg, 1.28 mmol) during 120 h, along with 3p (25.0 mg, 32%).
Method C: 15.0 mg (21%) from 1p (30.0 mg, 0.22 mmol) and 2a (42.6
mg, 0.44 mmol) during 9.5 h, along with 5/5'p (20.0 mg, 21%).
4p: pale yellow solid, mp 136-137 C; IR (2E,4Z and 2E,4E 1:1) 3193,
1
1706, 1658, 1620, 1588, 1517, 1331 cm1; H NMR (500.3 MHz, CDCl3,
This article is protected by copyright. All rights reserved.